HILL-ROM HOLDINGS, INC. (NYSE:HRC) Files An 8-K Results of Operations and Financial Condition
Item 2.02.
RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On January 25, 2019, Hill-Rom Holdings, Inc. (the “Corporation”) announced its earnings for the first quarter ended December 31, 2018. Please see the press release filed as Exhibit 99.1 to this Current Report on Form 8-K, which is incorporated herein by reference.
In the press release, the Corporation uses various non-GAAP measures, including adjusted gross margin, operating margin, income before taxes, income tax expense and diluted earnings per share results, because it uses these measures internally for planning, forecasting and evaluating the performance of the business. In addition, the Corporation analyzes net revenue on a constant currency basis to better measure the comparability of results between periods. The Corporation believes that evaluating growth in net revenue on a constant currency basis provides an additional and meaningful assessment to both management and investors. These measures should not, however, be considered in isolation, as a substitute for, or as superior to measures of financial performance prepared in accordance with GAAP.
|
Item 9.01. |
FINANCIAL STATEMENTS AND EXHIBITS. |
|
Press Release of Hill-Rom Holdings, Inc. dated January 25, 2019 – regarding the Corporation’s earnings for first quarter ended December 31, 2018 |
Hill-Rom Holdings, Inc. Exhibit
EX-99.1 2 a2019q1exhibit991.htm EXHIBIT 99.1 Exhibit Exhibit 99.1CONTACT INFORMATIONInvestor RelationsContact:Mary Kay Ladone,…
To view the full exhibit click here
About HILL-ROM HOLDINGS, INC. (NYSE:HRC)
Hill-Rom Holdings, Inc. is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions. The Company sells and rents its specialty frames and surfaces, and mobility solutions, as well as its clinical workflow solutions, in the United States and Canada through its North America Patient Support Systems segment, and in regions outside of the United States and Canada through its International Patient Support Systems segment. Its Front Line Care segment globally sells and rents respiratory care products, and sells medical diagnostic equipment and a diversified portfolio of devices that assess, diagnose, treat and manage a range of illnesses and diseases. Under its Surgical Solutions segment, the Company sells its surgical products globally.
